contract_award•Awarded Friday, August 21, 2026Analyzed

PFIZER INC: $45.5M Department of Health and Human Services Contract Vehicle

Bullish

Summary

Pfizer received a $45.5M contract from the CDC for pediatric COVID-19 vaccines for FY2026-27. The award is a routine renewal and represents a negligible fraction of Pfizer's annual revenue, with limited stock impact.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The $45.5M contract is a routine renewal for pediatric COVID vaccines, not a transformative event.
  • 2.Pfizer's massive revenue base means this award has negligible financial impact.
  • 3.No direct legislative connection; the contract is funded through existing HHS appropriations.

Market Implications

The contract is too small to move Pfizer's stock price. Investors should focus on broader catalysts like new drug approvals or pipeline developments. The pediatric vaccine market remains stable but commoditized, with limited growth potential for large-cap pharma.

Full Analysis

The Department of Health and Human Services, through the CDC, awarded Pfizer Inc a $45.5M indefinite delivery/indefinite quantity contract for pediatric COVID-19 vaccines under Executive Order 14398. The contract covers June 2026 to May 2027. Pfizer is the direct recipient and a publicly traded company. With FY2025 revenue of $59.6B, this contract is approximately 0.08% of annual revenue — a routine, non-material award. No related legislation directly authorizes this specific spending; it falls under existing pandemic preparedness authorities. Supply chain beneficiaries are limited as Pfizer manufactures its own vaccines; potential subcontractors include raw material suppliers like Thermo Fisher Scientific ($TMO) or packaging firms, but no specific downstream contracts are identified. Historically, similar vaccine procurement contracts provide steady but small revenue streams for large pharma companies and do not drive significant stock moves.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderOct 19, 2026

Advancing Women's Health to Improve Outcomes in All Phases of Life

This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.

Exec OrderSep 18, 2026

Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program

This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Contract Details

Recipient

PFIZER INC

Award Amount

$45,530,506

Awarding Agency

Department of Health and Human Services

Sub-Agency

Centers for Disease Control and Prevention

Contract Type

INDEFINITE DELIVERY / INDEFINITE QUANTITY

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →